Literature DB >> 31212180

Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement.

Gianfranco Fontana1, Maurizio Bruno2, Monica Notarbartolo3, Manuela Labbozzetta4, Paola Poma5, Alberto Spinella6, Sergio Rosselli7.   

Abstract

Oleanolic and ursolic acids are two ubiquitous isomeric triterpene phytochemicals known for their anticancer activity. A set of derivatives of the two compounds with a modified oxidation state and lipophylicity at C-3 and C-28 positions, were prepared and tested as anticancer agents versus the lines HepG2, Hep3B and HA22T/VGH of hepatocarcinoma, a strongly aggressive tumor that is not responsive toward the standard therapies. New derivatives containing a three carbons side chain on the C-3 position were synthetized in both stereoisomeric forms by the Barbier-Grignard procedure and three of them were found to be active toward all of the three targets. The implication of the transcriptional nuclear factor NF-κB in the mechanism of action was assessed for the more active compounds in the set, as hepatocellular carcinoma (HCC) cyto-types are known to overexpress NF-κB.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antitumor activity; HA22T/VGH; Hep3B; HepG2; NF−κB; Oleanolic acid; Ursolic acid

Year:  2019        PMID: 31212180     DOI: 10.1016/j.bioorg.2019.103054

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  9 in total

1.  Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth.

Authors:  Mengyue Shen; Duo Wang; Yusuke Sennari; Zirui Zeng; Ryoko Baba; Hiroyuki Morimoto; Noriaki Kitamura; Tsukasa Nakanishi; Junichi Tsukada; Masanobu Ueno; Yasuyuki Todoroki; Shigeru Iwata; Tomo Yonezawa; Yoshiya Tanaka; Yoshio Osada; Yasuhiro Yoshida
Journal:  Med Oncol       Date:  2022-06-08       Impact factor: 3.064

2.  Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway.

Authors:  Gianfranco Fontana; Natale Badalamenti; Maurizio Bruno; Davide Castiglione; Monica Notarbartolo; Paola Poma; Alberto Spinella; Marco Tutone; Manuela Labbozzetta
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 3.  Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View.

Authors:  Manuela Labbozzetta; Monica Notarbartolo; Paola Poma
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

4.  Antitumor Mechanism of the Essential Oils from Two Succulent Plants in Multidrug Resistance Leukemia Cell.

Authors:  Paola Poma; Manuela Labbozzetta; James A McCubrey; Aro Vonjy Ramarosandratana; Maurizio Sajeva; Pietro Zito; Monica Notarbartolo
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-26

Review 5.  Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update.

Authors:  Vuyolwethu Khwaza; Opeoluwa O Oyedeji; Blessing A Aderibigbe
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

6.  Decrease of ABCB1 protein expression and increase of G1 phase arrest induced by oleanolic acid in human multidrug-resistant cancer cells.

Authors:  Didi Wang; Jincai Wang; Juan Zhang; Xin Yi; Jinhua Piao; Li Li; Jianjie Wang; Pengxia Zhang; Qiyang He
Journal:  Exp Ther Med       Date:  2021-05-09       Impact factor: 2.447

7.  16-Tigloyl linked barrigenol-like triterpenoid from Semen Aesculi and its anti-tumor activity in vivo and in vitro.

Authors:  Yiren Yang; Liping Long; Xinxin Zhang; Kairu Song; Da Wang; Xin Xiong; Huiyuan Gao; Luping Sha
Journal:  RSC Adv       Date:  2019-10-07       Impact factor: 4.036

Review 8.  Therapeutic Potential of Ursonic Acid: Comparison with Ursolic Acid.

Authors:  Juhyeon Son; Sang Yeol Lee
Journal:  Biomolecules       Date:  2020-11-02

9.  Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia.

Authors:  Manuela Labbozzetta; Paola Poma; Marco Tutone; James A McCubrey; Maurizio Sajeva; Monica Notarbartolo
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.